A Novel Nanoparticle Method for Drug Delivery in Sepsis Treatment
Understanding Sepsis and Its Challenges
Sepsis is a severe and life-threatening complication that can arise from significant bacterial infections. It is characterized by the body’s inflammatory response to infection, which can inadvertently harm its own organs, potentially leading to organ failure and death. While numerous therapeutic agents have been identified for sepsis management, the effective delivery of these treatments to the sites of infection remains a significant hurdle.
Limitations of Current Antibiotic Practices
Current approaches to sepsis management typically involve administering antibiotics and anti-inflammatory medications. In cases of early detection, these are often given orally, whereas intravenous administration is employed for more severe cases. However, oral antibiotics face absorption issues, as they are quickly metabolized and poorly absorbed by the body, resulting in reduced efficacy. This necessitates higher dosages, which can lead to adverse toxic effects due to poor selectivity.
Innovative Nanoparticle Delivery System
To tackle these challenges, researchers at Washington State University have developed a selective nanoparticle delivery system aimed at improving the management of sepsis. Their findings were recently published in the journal Advanced Materials.
The nanoparticle system comprises drug-loaded co-polymers that respond to changes in acidity and bacterial enzymes, which are indicators of infection sites. Notably, these nanoparticles are coated with antibodies that the body produces in response to infection, ensuring that the antibiotic and anti-inflammatory agents are released only upon reaching the targeted infection site.
Promising Results from Animal Testing
The nanoparticle drug delivery system has undergone testing in mice suffering from sepsis induced by acute lung infection. Results indicated that approximately 90% of mice treated with the nanoparticle-coated antibiotics survived, compared to only 40% survival in those treated with the free drug.
This innovative nanoparticle represents a significant advancement in drug delivery technology and contributes to the increasing role of nanotechnology in medicine. The study’s authors express optimism that this new method will lead to more effective drug formulations for a variety of bacterial infections.
References
Zhang CY, Gao J, Wang Z. Bioresponsive Nanoparticles Targeted to Infectious Microenvironments for Sepsis Management. Adv Mater. 2018 Sep 11:e1803618. doi: 10.1002/adma.201803618. [Epub ahead of print]
WSUNews. New nanoparticles wait to release drugs, target infection. EurekAlert! https://www.eurekalert.org/pub_releases/2018-09/wsu-nnw091018.php. Published September 11, 2018.